Filing Details
EXAGEN INC. (NASDAQ:XGN) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event.
8k filedNASDAQ:XGN
EXAGEN INC. (XGN) Reports Material Event to SEC
Filing Details EXAGEN INC. (NASDAQ:XGN) filed a Form 8-K with the Securities and Exchange Commission on August 04, 2026, disclosing a material event. Market Context EXAGEN INC.'s…
Market Context
EXAGEN INC.'s stock currently trades at $6.45 with a market capitalization of $163.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for EXAGEN INC.'s stock.
All SEC filings for EXAGEN INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View XGN Stock Page
Frequently Asked Questions
Where can I read XGN's SEC filings?
Browse all filings on our XGN SEC filings page.
What types of SEC filings does EXAGEN INC. file?
Public companies like EXAGEN INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
